Both in Biotechnology
Creative Medical Technology Holdings vs PharmaCyte Biotech
Over the past year CELZ returned −87.1% and PMCB returned −66.0%; their daily moves had a correlation of 0.14.
CELZ −87.1% PMCB −66.0%Growth of $1, one year, split-adjusted
| Metric | CELZ | PMCB |
|---|---|---|
| Price | $0.7200 | $0.3347 |
| Market cap | $5.5M | $3.6M |
| Today | +4.32% | −2.45% |
| 1 month | −25.4% | −20.1% |
| 6 months | −67.6% | −55.4% |
| Year to date | −63.3% | −53.8% |
| 1 year | −86.0% | −66.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,822.2× | — |
| Net cash | $8.7M | $30.5M |
| Dividend yield | — | — |
| Volatility (60d) | 145.2% | 61.5% |
| Short % of float | 2.2% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).